TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination-Reference-Cited by-同舟云学术

TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination

Published:2020-08 Issue: Volume:152 Page:102987
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Roviello Giandomenico^ORCID,Fancelli Sara,Gatta Michelet Marta Rita,Aprile Giuseppe,Nobili Stefania,Roviello Franco,Cianchi Fabio,Mini Enrico,Lavacchi Daniele

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference74 articles.

1. Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update;Amstutz;Clin. Pharmacol. Ther.,2018

2. Anon 2020 https://www.pharmgkb.org.

3. Phase I and II studies of 2’-deoxy-5-(trifluoromethyl)-uridine (NSC-75520);Ansfield;Cancer Chemother. Rep.,1971

4. A multicenter phase II study of TAS-102 monotherapy in patients with pre-treated advanced gastric cancer (EPOC1201);Bando;Eur. J. Cancer,2016

5. Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300;Bang;Ann. Oncol.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case report;Journal of Gastrointestinal Oncology;2023-12

2. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives;Phytotherapy Research;2023-05-08

3. Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done;Current Oncology;2022-09-08

4. Treatment Strategy for Oligometastatic Gastric Cancer: Brief Considerations;Journal of Gastrointestinal Cancer;2022-01-30

5. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality;Future Oncology;2021-11